newsfilter
← Earnings
Earnings Releases·

Alpha Teknova, Inc. — Third Quarter 2026 Earnings Summary

Alpha Teknova, Inc. reported third-quarter 2026 total revenue of $12.7 million, representing a 22% increase compared to the same period in 2025. The company raised its full-year 2026 revenue guidance to a range of $46 million to $48 million while maintaining an expectation for free cash outflow of less than $8 million. In October 2026, Teknova completed a public equity offering that generated $46 million in gross proceeds, strengthening its balance sheet with total cash and short-term investments reaching $16.6 million by the end of the quarter. Net loss for the quarter narrowed to $3.5 million, or $0.06 per diluted share, from $4.3 million in the prior year period.

Company
ALPHA TEKNOVA INC
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic